Inmolecule Nanotech (XPAR:MLINA) EV-to-EBITDA: (As of Aug. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:MLINA Inmolecule Nanotech SA XPAR:MLINA
7 GF Score
Price €4.08
! 2 Warning Signs
View Full Analysis

What is Inmolecule Nanotech EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Inmolecule Nanotech's enterprise value is €32.52 Mil. Inmolecule Nanotech does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Dec. 2024. Therefore, GuruFocus does not calculate Inmolecule Nanotech's EV-to-EBITDA at this moment.

The historical rank and industry rank for Inmolecule Nanotech's EV-to-EBITDA or its related term are showing as below:

XPAR:MLINA' s EV-to-EBITDA Range Over the Past 10 Years
Min: 0   Med: 0   Max: 878.89
Current: 878.89

During the past 2 years, the highest EV-to-EBITDA of Inmolecule Nanotech was 878.89. The lowest was 0.00. And the median was 0.00.

XPAR:MLINA's EV-to-EBITDA is ranked worse than
98.77% of 407 companies
in the Biotechnology industry
Industry Median: 14.17 vs XPAR:MLINA: 878.89

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2026-08-23), Inmolecule Nanotech's stock price is €4.08. Inmolecule Nanotech does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024. Therefore, GuruFocus does not calculate Inmolecule Nanotech's PE Ratio (TTM) at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Inmolecule Nanotech  (XPAR:MLINA) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Inmolecule Nanotech's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=4.08/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Inmolecule Nanotech EV-to-EBITDA Related Terms


Inmolecule Nanotech EV-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Inmolecule Nanotech's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inmolecule Nanotech EV-to-EBITDA Chart

Inmolecule Nanotech Annual Data
Trend Dec23 Dec24
EV-to-EBITDA
0.00 0.00

Inmolecule Nanotech Semi-Annual Data
Dec23 Dec24
EV-to-EBITDA 0.00 0.00

XPAR:MLINA vs VRTX, REGN, RVMD: EV-to-EBITDA Comparison

For the Biotechnology subindustry, Inmolecule Nanotech's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inmolecule Nanotech EV-to-EBITDA vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Inmolecule Nanotech's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Inmolecule Nanotech's EV-to-EBITDA falls into.


XPAR:MLINA
7GF Score
Inmolecule Nanotech SA XPAR:MLINA
EV-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inmolecule Nanotech EV-to-EBITDA Calculation

Inmolecule Nanotech's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=32.519/
=


Inmolecule Nanotech Business Description

Address Paseo de la Castellana 91, 4th Floor, Madrid, ESP, 28046
Inmolecule Nanotech SA is a research and development company. The company provides health care, home care and personal care products.
7GF Score

Get the complete analysis for XPAR:MLINA

EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.08
Price